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呼吸器系に作用する薬  
Ａ．気管支喘息とその治療薬   
 １．気管支喘息bronchial asthma   
 ２．メチルキサンチン薬methylxanthine   
 ３．β2受容体作動薬β2-Adrenergic agonist 
 ４．吸入抗コリン薬   inhaled anticholinergics (muscarinic 
antagonist) 
 ５．コルチコステロイド薬corticosteroid; inhaled 
corticosteroid (ICS)   
 ６．抗アレルギー薬・抗ロイコトリエン(LTD4)薬 
Ｂ．慢性閉塞性肺疾患（COPD）とその治療薬； 咳の機序 






• 気道の過敏性亢進、気道のリモデリングが基礎  




• 吸入式の薬物投与方法  
Mechanisms Underlying the Definition of Asthma 
http://www.nhlbi.nih.gov/guidelines/asthma/ 
Coughing, shortness of breath, & wheezing dyspnea  
Obstructive 
Inverse Relation between the Incidence of Prototypical Infectious Diseases 
(Panel A) and the Incidence of Immune Disorders (Panel B) from 1950 to 2000. 
                    NEJM Bach 347 (12): 911, Figure 1     September 19, 2002 























































































• 呼吸生理学; FEV1(%) 
– Spirometry; Peak flowmeter 
• 閉塞性；拘束性 
 
• 気管支喘息の病理・病態  
– Bronchospasm (2 phases) 
– Th2 inflammation 
– Mast cell; chemical mediators 
– Remodeling 















































FEV1 ／ VC 





























peak expiratory flow；PEF 
1秒量; 1秒率FEV1.0% 
FEV1.0%: forced expiratory 
volume in one second percent 
肺活量 vital capacity (%) 100 0 




































体）の浸潤がみられる。（Color Atlas of Respiratory Disease, Vol 2. Allen & Humburys, 
1995より。岩手県立中央病院病理センター富地信和先生の提供による） 
Specimen of Bronchial Mucosa from a 
Subject without Asthma (Panel A) and a 
Patient with Mild Asthma (Panel B) 
(Hematoxylin and Eosin, x40). 
In the subject without asthma, the 
epithelium is intact; there is no 
thickening of the sub-basement 
membrane, and there is no cellular 
infiltrate.  
In contrast, in the patient with mild 
asthma, there is evidence of goblet-
cell hyperplasia in the epithelial-cell 
lining. The sub-basement 
membrane is thickened, with 
collagen deposition in the submucosal 
area, and there is a cellular infiltrate.  
 Busse and Lemanske: NEJM 344 (5): 350, 
Figure 1     February 1, 2001  
 
The Importance of Establishing a Balance between Th1-Type and Th2-Type Cytokine Responses. 
Numerous factors, including alterations in the number or type of infections early in life, the widespread use of 
antibiotics, adoption of the Western lifestyle, and repeated exposure to allergens, may affect the balance between Th1-
type and Th2-type cytokine responses and increase the likelihood that the immune response will be dominated by Th2 
cells and thus will ultimately lead to the expression of allergic diseases such as asthma. 
Busse and Lemanske: NEJM 344 (5): 350, Figure 4     February 1, 2001  
A Simplified Scheme of the System of Type 1 




Schwartz 346 (11): NEJM 857, Figure 1   March 14, 2002 
The Role of Eosinophils in Allergic Inflammation. 
NEJM Busse and Lemanske 344 (5): 350, Figure 3 , 2001 
Inhaled antigen activates mast cells and Th2 
cells in the airway. They in turn induce the 
production of mediators of inflammation 
(such as histamine and leukotrienes) and 
cytokines including interleukin-4 and 
interleukin-5. Interleukin-5 travels to the bone 
marrow and causes terminal differentiation of 
eosinophils. Circulating eosinophils enter the 
area of allergic inflammation and begin 
migrating to the lung by rolling, through 
interactions with selectins, and eventually 
adhering to endothelium through the binding 
of integrins to members of the immuno-
globulin superfamily of adhesion proteins: 
vascular-cell adhesion molecule 1 (VCAM-1) 
and intercellular adhesion molecule 1 (ICAM-
1). As the eosinophils enter the matrix of the 
airway through the influence of various 
chemokines and cytokines, their survival is 
prolonged by interleukin-5 and granulocyte–
macrophage colony-stimulating factor (GM-
CSF). On activation, the eosinophil releases 
inflammatory mediators such as leukotrienes 
and granule proteins to injure airway tissues. 
In addition, eosinophils can generate 
granulocyte–macrophage colony-stimulating 
factor to prolong and potentiate their survival 
and contribution to persistent airway 
inflammation. MCP-1 denotes monocyte 
chemotactic protein, and MIP-1 macrophage 
inflammatory protein. 


















































































MBP (major basic protein), ECP (eosinophil cationic protein), EDN (eosinophil-derived 
neurotoxin)は、いずれも好酸球から遊離され、気道上皮細胞を傷害する 

The Airway in a Healthy Person (Panel A) and in a Patient 
with Asthma (Panel B). 
In Panel A, the airway of a healthy person is composed of an 
epithelium with a thin basement membrane and some relatively 
quiescent fibroblasts and smooth-muscle cells. Minimal expression 
of ADAM-33 may maintain base-line levels of cell proliferation and 
basement-membrane integrity. In Panel B, the airway of a patient 
with asthma is characterized by subepithelial fibrosis (with collagen 
deposition), smooth-muscle hypertrophy or hyperreactivity, and 
inflammation. ADAM-33 could participate in these abnormal 
processes through loss-of-function polymorphisms (by down-
regulating the shedding of growth factor receptor) or gain-of-
function mutations (by increasing the shedding of growth factors 
with autocrine or paracrine effects on fibroblasts and smooth-muscle 
cells). ADAM-33 might also be involved in the chronic immune or 
inflammatory response through the excessive shedding of type 2 
helper T cell (Th2) cytokines or by impaired shedding of cytokine 
receptors (macrophage shown). 
Shapiro and Owen NEJM 347 (12): 936, Figure 1     September 19, 2002 
２．メチルキサンチン薬methylxanthines   
• テオフィリンtheophylline（徐放性剤型 ） 







④IgE受容体刺激に共役するCa2+流入抑制作用    
Second messengers vs. anti-inflammation & bronchodilation 
3. Structure of β-Adrenergic Bronchodilators. 
Adrenaline 
Salbutamol  
long-acting β2-agonists (LABA). 
NEJM 333:499-507  August 24, 1995 
β2-Adrenergic agonists are the most effective bronchodilators for the treatment 
of acute episodes of asthma and for the prevention of exercise-induced 
bronchoconstriction. The LABAs prevent nocturnal asthma and provide prolonged 
protection against exercise-induced bronchoconstriction. LABAs should be 
administered only at regular, prescribed intervals. Additional doses should not be 
given to relieve symptoms; intermediate-acting β2-agonists should be given instead. 
Despite some concern about these drugs as a class, the adverse effects are probably 
related more closely to the severity of the asthma than to the drug.  Thus, β2-
adrenergic agonists remain the most important class of bronchodilators currently 
available. When used appropriately, they provide safe and effective relief of the 
















inhaled corticosteroid (ICS) 


















ステロイド薬とβ2刺激薬の相補的作用complementary effect  
ステロイド薬とβ2刺激薬の相乗効果synergistic effect  
 Effect of the Interaction between the Intensity of Exercise and the Thermal Environment on the 
Pulmonary Mechanical Response. Relative Effects of Various Drugs on Airway Obstruction 
Induced by Thermal Stimuli. 
FEV1 denotes forced expiratory volume in one second, VE: minute ventilation. The data were obtained by 
generating stimulus-response curves during isocapnic hyperventilation with frigid air before and after the 
administration of placebo and common anti-asthma drugs alone and in combination. This information 
represents our composite experience with the agents. NEJM 330:1362-1367  May 12, 1994  Exercise-
Induced Asthma E.R. McFadden, and Ileen A. Gilbert  
６．抗アレルギー薬・ 
抗ロイコトリエン(LTD4)薬 
• クロモグリク酸cromoglycate  











• トロンボキサンA2（TXA2）合成酵素阻害薬（オザグレル）  
• スプラタストsuplatast（TH2サイトカイン阻害薬）：は IL-4，5と
IgE産生抑制作用  
Drugs on the 5-Lipoxygenase Pathway. Drazen et al. NEJM 340 (3): 197, 1999 
Biochemical Pathways of the Formation and Action of the Leukotrienes and Sites of Action of Leukotriene-
Modifying Drugs. Enzymes are shown in blue, products in yellow, essential cofactor in green, and drugs in red. 
Although the synthesis of leukotrienes B4 and C4 probably takes place in close proximity to the nuclear membrane, 
for clarity they are shown throughout the cytosol. BLT denotes the B leukotriene receptor. An individual cell may 



























Exposure to antigen 
(dust, pollen, etc) 
Avoidance 
Antigen and IgE 
on mast cells 
Mediators  






























• 禁煙が極めて重要  












































POET（Prevention Of Exacerbations with Tiotropium）試験、
NEJM誌2011年3月24日号 
COPD増悪予防にはサルメテロールよりチオトロピウム




































ある。  喘息マウスでのgob-5遺伝子 
